language_icon
EN
HI

Bliss GVS Pharma Share price

BLISSGVS

290.05

7.25 (2.56%)
NSE
BSE
Last updated on 20 May, 2026 | 15:58 IST
Today's High

292.00

Today's Low

278.55

52 Week Low

118.00

52 Week High

296.30

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Bliss GVS Pharma Chart

Bliss GVS Pharma Share Key Metrics

Volume
11.40 L
Market Cap
3068.41 CR
LTQ@LTP
293@290.05
ATP
285.64
Var Margin
26.97 %
Circuit Range
226.25-339.35
Delivery %
36.78 %
Value
32.56 CR
ASM/GSM
No
Market Lot
1

Summary

Bliss GVS Pharma share price is ₹290.05 as of 21 May, 2026. The stock Bliss GVS Pharma intraday movement has stayed between ₹278.55 and ₹292.00, while on a 52-week basis,Bliss GVS Pharma price 52 week high is ₹296.30 & its 52 week low is ₹118.00.
In terms of trading activity, Bliss GVS Pharma has recorded a volume of 1139806 shares, The Bliss GVS Pharma has a market cap of ₹105788972 CR. The stock’s Average Traded Price (ATP) stands at ₹285.64, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 293 @ ₹290.05.
Bliss GVS Pharma operates within a circuit range of ₹226.25 – ₹339.35, with a Value of ₹32.56 CR. The Delivery Percentage for the day is 36.78%. Additionally, Bliss GVS Pharma currently falls under the No framework, and trades with a market lot size of 1.

Bliss GVS Pharma Fundamentals

View More
P/E Ratio

23.19

P/B Ratio

2.51

Div. Yield

0.35

Sector P/E

71.7

Sector P/B

3.51

Sec. Div. Yield

0.56

Bliss GVS Pharma Resistance and Support

Pivot 286.25

Resistance

First Resistance

292.85

Second Resistance

302.9

Third Resistance

309.5

Support

First Support

276.2

Second Support

269.6

Third Support

259.55

Bliss GVS Pharma Shareholding Pattern

View More
  • 2016-17
  • 2017-18
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

35.36%

Mutual Fund

0%

Insurance

4.33%

Foreign Institutional Investors

10.45%

Domestic Institutional Investors

0.71%

Retail

49.15%

Others

0%

Total Promoters
MAR '26
35.36%

Bliss GVS Pharma Corporate Actions

DateAgenda
2026-05-12Audited Results & Final Dividend
2026-02-10Quarterly Results & Interim Dividend
2025-11-06Quarterly Results
2025-07-29Quarterly Results
2025-05-12Audited Results & Final Dividend
2025-01-28Quarterly Results & Others

Bliss GVS Pharma News

Bliss GVS Pharma Ltd - 506197 - Corporate Action-Board approves Dividend

Bliss GVS Pharma Board recommended a final dividend of ₹1 per equity share for FY26. The 100% dividend on a ₹1 face value is subject to shareholder approval at the 41st AGM on July 15, 2026.
May 12 2026 22:05:00

Bliss GVS Pharma Ltd - 506197 - Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday, May 12, 2026

Bliss GVS Pharma board approved audited financial results for FY26, reporting cons. revenue of ₹846.22 cr (up 4.51% YoY) and net profit of ₹97.26 cr (up 14.33% YoY). The company recommended a final dividend of ₹1 per equity share and re-appointed BDO India Services Private Limited as internal auditor for FY27.
May 12 2026 22:05:00

Bliss GVS Pharma Limited

BLISS GVS PHARMA's board is scheduled to meet on May 12, 2026. The agenda includes considering the audited financial results for the fiscal year ended March 2026, along with a proposal for a final dividend.
May 05 2026 18:05:00

Bliss GVS Pharma Ltd - 506197 - Board Meeting Intimation for Approval Of Audited (Standalone & Consolidated) Financial Results Of The Company For The Quarter And Year Ended March 31, 2026 And Recommendation Of Final Dividend If Any, For The Year Ended March 31, 2026.

Bliss GVS Pharma's Board of Directors is scheduled to meet on May 12, 2026. The agenda includes considering and approving the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and recommending a final dividend for FY26.
May 05 2026 18:05:00
Read More

About Bliss GVS Pharma

NSE : 19265  
BSE : 506197  
ISIN : INE416D01022  

Bliss GVS Pharma Management

NamePosition
Aditi BhattCompany Secretary & Compliance Officer
Nandkumar chodankarChairman
View More

Bliss GVS Pharma FAQs

The Buying Price of Bliss GVS Pharma share is 290.05 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Bliss GVS Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Bliss GVS Pharma, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Bliss GVS Pharma shares is 23.19. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Bliss GVS Pharma shares is 2.51. Useful to assess the stock's value relative to its book value.

To assess Bliss GVS Pharma’s valuation compare Sector P/E, P/B which are 71.7 & 3.51 with sector averages, along with growth rates and financial metrics.

The Market Cap of Bliss GVS Pharma is 3068.41 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Bliss GVS Pharma share price is 296.30 & 118.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Bliss GVS Pharma belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost